This is a discussion on DERP releases final report on topical calcineurin inhibitors (TCIs) within the Comparative Effectiveness Updates forum, part of the Industry News and Updates category; The Oregon Health and Science University's Drug Effectiveness Review Project (DERP) released it's final report on topical calcineurin ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
The Oregon Health and Science University's Drug Effectiveness Review Project (DERP) released it's final report on topical calcineurin inhibitors (TCIs), pimecrolimus and tacrolimus, used in the treatment of atopic dermatitis and eczema. The report addresses comparison to topical corticosteroids, safety issues and special population considerations.
Source: DERP Final Report |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| DERP releases final report on antiepileptics | chantell.reagan | Comparative Effectiveness Updates | 0 | 11-13-2008 11:00 AM |
| Novo Nordisk releases more liraglutide data | industry_news | Biotechnology News | 0 | 10-17-2008 11:54 AM |
| Topical Cyclosporine May Be Helpful for Dry Eye Disease | industry_news | Other Clinical Pharmacy News | 0 | 08-12-2008 09:46 PM |
| Amgen releases positive denosumab results | industry_news | Biotechnology News | 0 | 07-14-2008 03:25 PM |
| AtheroGenics releases diabetes data | industry_news | Biotechnology News | 0 | 06-23-2008 03:17 PM |